Division of HIV Prevention (DHP) Strategic Plan
Message from the Director
I am pleased to present a supplement to the Division of HIV Prevention (DHP) Strategic Plan, which includes an overview of refreshed priorities and investment areas to guide our work from 2022 to 2025. In October 2021, DHP implemented a more fit-for-purpose organizational structure that fosters enhanced collaboration between scientific and programmatic activities to drive meaningful, lasting change in communities affected by HIV. The new structure helps to modernize and better position DHP to address the Division’s key priorities with renewed energy, direction, and focus. In line with the new organizational structure was a need to refresh the existing plan to better fit the new operating model.
This document is meant to supplement the 2017-2020 Strategic Plan as well as align with goals outlined in the 2022-2025 National HIV/AIDS Strategy (NHAS) and the Ending HIV Epidemic (EHE) in the U.S. Initiative. It builds on DHP’s existing goals, objectives, strategies, and indicators to serve as a practical guide to inform the Division’s work. The process by which we developed this document was guided by DHP’s core values and a set of guiding principles that served to ensure the output of the process was true to the spirit of the Division. The supplement was developed in collaboration with DHP staff and other partners to best capture the Division’s most pressing needs and identify the steps to address them.
The current DHP strategy uses the EHE pillars (Diagnose, Treat, Prevent, Respond) as its foundation. With this supplement, we aim to integrate the pillars with new priorities and investments to position DHP to not only achieve the goals of EHE but to also respond to future national initiatives. This supplement emphasizes four cross-cutting focus areas within DHP’s core programmatic and scientific portfolio—health equity, community engagement, and syndemic and status neutral approaches—and it details new areas of investment in both time and resources that the Division can use to affect change. The six investment areas detailed in this supplement are:
- Strengthening DHP’s Workforce and Organizational Capacity
- Expanding Access to and Use of DHP Funding
- Enhancing Implementation Guidance and Technical Assistance
- Integrating Data and Data Systems
- Advancing Partnerships and Increasing Collaboration
- Supporting Partner and Recipient Communication Efforts
While significant progress has been made in the fight against HIV, much remains to be done to end this epidemic. These investments position DHP to continue to lead and guide HIV prevention, care, and treatment domestically in collaboration with our partners as we work toward a future free of HIV. I look forward to collaborating with you to achieve the priorities outlined in this supplement as we work toward ending the HIV epidemic in the United States.
Dr. Demetre Daskalakis, MD, MPH
Director, Division of HIV Prevention, Centers for Disease Control and Prevention